• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺癌细胞来源的细胞外囊泡通过免疫介导机制促进上皮间质转化(EMT)和恶性表型转移。

Extra-Cellular Vesicles Derived from Thyroid Cancer Cells Promote the Epithelial to Mesenchymal Transition (EMT) and the Transfer of Malignant Phenotypes through Immune Mediated Mechanisms.

机构信息

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.

出版信息

Int J Mol Sci. 2023 Feb 1;24(3):2754. doi: 10.3390/ijms24032754.

DOI:10.3390/ijms24032754
PMID:36769076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9917007/
Abstract

Thyroid cancer is the most common endocrine cancer, and its incidence is increasing in many countries around the world. Among thyroid cancers, the papillary thyroid cancer (PTC) histotype is particularly prevalent. A small percentage of papillary tumors is associated with metastases and aggressive behavior due to de-differentiation obtained through the epithelial-mesenchymal transition (EMT) by which epithelial thyroid cells acquire a fibroblast-like morphology, reduce cellular adhesion, increase motility and expression of mesenchymal proteins. The tumor microenvironment plays an important role in promoting an aggressive phenotype through hypoxia and the secretion of HMGB1 and other factors. Hypoxia has been shown to drastically change the tumor cell phenotype and has been associated with increasing metastatic and migratory behavior. Cells transfer information to neighboring cells or distant locations by releasing extracellular membrane vesicles (EVs) that contain key molecules, such as mRNAs, microRNAs (miRNAs), and proteins, that are able to modify protein expression in recipient cells. In this study, we investigated the potential role of EVs released by the anaplastic cancer cell line CAL-62 in inducing a malignant phenotype in a papillary cancer cell line (BCPAP).

摘要

甲状腺癌是最常见的内分泌癌,在世界上许多国家的发病率都在增加。在甲状腺癌中,乳头状甲状腺癌(PTC)组织学类型尤为普遍。一小部分乳头状肿瘤由于上皮-间充质转化(EMT)而与转移和侵袭性行为相关,通过 EMT,上皮甲状腺细胞获得成纤维细胞样形态,减少细胞黏附,增加运动性和间充质蛋白的表达。肿瘤微环境通过缺氧和高迁移率族蛋白 B1(HMGB1)等因素的分泌,在促进侵袭性表型方面发挥重要作用。缺氧显著改变肿瘤细胞表型,并与转移和迁移行为增加相关。细胞通过释放含有关键分子(如 mRNAs、microRNAs(miRNAs)和蛋白质)的细胞外膜囊泡(EVs),将信息传递给邻近细胞或远处位置,这些关键分子能够修饰受体细胞中的蛋白质表达。在这项研究中,我们研究了源自间变性癌细胞系 CAL-62 的 EVs 在诱导乳头状癌细胞系(BCPAP)产生恶性表型中的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93e3/9917007/9d5f02374c19/ijms-24-02754-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93e3/9917007/1a24c746c984/ijms-24-02754-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93e3/9917007/c2cb13f94df8/ijms-24-02754-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93e3/9917007/1ae06ff97405/ijms-24-02754-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93e3/9917007/9d5f02374c19/ijms-24-02754-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93e3/9917007/1a24c746c984/ijms-24-02754-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93e3/9917007/c2cb13f94df8/ijms-24-02754-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93e3/9917007/1ae06ff97405/ijms-24-02754-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93e3/9917007/9d5f02374c19/ijms-24-02754-g004.jpg

相似文献

1
Extra-Cellular Vesicles Derived from Thyroid Cancer Cells Promote the Epithelial to Mesenchymal Transition (EMT) and the Transfer of Malignant Phenotypes through Immune Mediated Mechanisms.甲状腺癌细胞来源的细胞外囊泡通过免疫介导机制促进上皮间质转化(EMT)和恶性表型转移。
Int J Mol Sci. 2023 Feb 1;24(3):2754. doi: 10.3390/ijms24032754.
2
Gene expression profile of epithelial-mesenchymal transition mediators in papillary thyroid cancer.甲状腺乳头癌中上皮-间质转化介体的基因表达谱。
Endocrine. 2021 May;72(2):452-461. doi: 10.1007/s12020-020-02466-3. Epub 2020 Sep 10.
3
5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.5'-腺苷酸激活蛋白激酶调节甲状腺乳头状癌(TPC-1和BCPAP)细胞的存活、迁移、侵袭及上皮-间质转化
Thyroid. 2016 Jul;26(7):933-42. doi: 10.1089/thy.2015.0440. Epub 2016 Jun 3.
4
MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.miR-520a-3p 通过 JAK1 介导的 JAK/STAT 信号通路抑制甲状腺乳头状癌细胞的上皮-间充质转化、侵袭和迁移。
J Cell Physiol. 2019 Apr;234(4):4054-4067. doi: 10.1002/jcp.27199. Epub 2018 Sep 12.
5
LRRC52-AS1 is associated with clinical progression and regulates cell migration and invasion in papillary thyroid cancer.LRRC52-AS1 与临床进展相关,并调节甲状腺乳头状癌中的细胞迁移和侵袭。
Clin Exp Pharmacol Physiol. 2020 Apr;47(4):696-702. doi: 10.1111/1440-1681.13229. Epub 2020 Jan 22.
6
microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.microRNA-539 通过靶向分泌白细胞蛋白酶抑制剂在甲状腺乳头状癌中作为肿瘤抑制因子通过转化生长因子β1/Smads 信号通路发挥作用。
J Cell Biochem. 2019 Jun;120(6):10830-10846. doi: 10.1002/jcb.28374. Epub 2019 Jan 31.
7
Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 α/β pathways.连接黏附分子-A 在间变性甲状腺癌中下调,并通过调节 p53 和 GSK3α/β 通路降低癌细胞的侵袭性。
Mol Carcinog. 2019 Jul;58(7):1181-1193. doi: 10.1002/mc.23001. Epub 2019 Mar 4.
8
Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.Podoplanin (PDPN) 通过与基质金属蛋白酶一起诱导 ezrin、radixin 和 moesin (E/R/M) 的磷酸化,影响甲状腺癌细胞的侵袭性。
BMC Cancer. 2019 Jan 17;19(1):85. doi: 10.1186/s12885-018-5239-z.
9
High expression of LINC0163 promotes progression of papillary thyroid cancer by regulating epithelial-mesenchymal transition MITF.LINC0163 的高表达通过调节上皮-间充质转化 MITF 促进甲状腺乳头状癌的进展。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5504-5511. doi: 10.26355/eurrev_202005_21335.
10
Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling.蒲公英甾醇通过调控 Wnt/β-连环蛋白信号通路抑制转化生长因子-β1 诱导的甲状腺乳头状癌细胞上皮间质转化。
Hum Exp Toxicol. 2021 Dec;40(12_suppl):S87-S95. doi: 10.1177/09603271211023792. Epub 2021 Jul 5.

引用本文的文献

1
Navigating thyroid cancer complexity: the emerging role of EV-derived non-coding RNAs.应对甲状腺癌的复杂性:细胞外囊泡衍生的非编码RNA的新作用
Cell Death Discov. 2025 Apr 4;11(1):142. doi: 10.1038/s41420-025-02411-1.
2
Prognostic value of EMT-related genes and immune cell infiltration in thyroid carcinoma.甲状腺癌中 EMT 相关基因和免疫细胞浸润的预后价值。
Front Immunol. 2024 Nov 4;15:1463258. doi: 10.3389/fimmu.2024.1463258. eCollection 2024.
3
MiRNAs in Extracellular Vesicles as Biomarkers in Plasma of Papillary Thyroid Cancer Patients: A Proof-of-Concept Study.

本文引用的文献

1
Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer.肝癌中的缺氧、代谢重编程与耐药性
Cells. 2021 Jul 6;10(7):1715. doi: 10.3390/cells10071715.
2
Immune Landscape of Thyroid Cancers: New Insights.甲状腺癌的免疫全景:新的见解。
Front Endocrinol (Lausanne). 2021 Apr 27;11:637826. doi: 10.3389/fendo.2020.637826. eCollection 2020.
3
KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma.KLF4、Slug 和 EMT 在头颈部鳞状细胞癌中的作用。
甲状腺乳头状癌患者血浆中细胞外囊泡内的微小RNA作为生物标志物:一项概念验证研究。
Biology (Basel). 2024 Sep 22;13(9):743. doi: 10.3390/biology13090743.
4
Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases.解决外泌体和核受体相互作用:慢性疾病治疗的新兴范例。
Mil Med Res. 2024 Sep 26;11(1):67. doi: 10.1186/s40779-024-00564-1.
5
HHV-6A Infection of Papillary Thyroid Cancer Cells Induces Several Effects Related to Cancer Progression.HHV-6A 感染甲状腺乳头状癌细胞诱导与癌症进展相关的多种效应。
Viruses. 2023 Oct 19;15(10):2122. doi: 10.3390/v15102122.
6
Tumor-associated macrophages as a potential therapeutic target in thyroid cancers.肿瘤相关巨噬细胞作为甲状腺癌潜在的治疗靶点。
Cancer Immunol Immunother. 2023 Dec;72(12):3895-3917. doi: 10.1007/s00262-023-03549-6. Epub 2023 Oct 5.
7
Identification an innovative classification and nomogram for predicting the prognosis of thyroid carcinoma patients and providing therapeutic schedules.鉴定一种创新的分类和列线图,用于预测甲状腺癌患者的预后,并提供治疗方案。
J Cancer Res Clin Oncol. 2023 Nov;149(16):14817-14831. doi: 10.1007/s00432-023-05252-6. Epub 2023 Aug 18.
Cells. 2021 Mar 3;10(3):539. doi: 10.3390/cells10030539.
4
Hypoxia-induced epithelial to mesenchymal transition in cancer.缺氧诱导的癌症上皮间质转化。
Cancer Lett. 2020 Sep 1;487:10-20. doi: 10.1016/j.canlet.2020.05.012. Epub 2020 May 26.
5
MicroRNA-9 and breast cancer.微小 RNA-9 与乳腺癌。
Biomed Pharmacother. 2020 Feb;122:109687. doi: 10.1016/j.biopha.2019.109687. Epub 2019 Dec 30.
6
Multikinase Inhibitor Treatment in Thyroid Cancer.多激酶抑制剂治疗甲状腺癌。
Int J Mol Sci. 2019 Dec 18;21(1):10. doi: 10.3390/ijms21010010.
7
HMGB1: an overview of its versatile roles in the pathogenesis of colorectal cancer.HMGB1:在结直肠癌发病机制中的多功能作用概述。
Cell Oncol (Dordr). 2020 Apr;43(2):177-193. doi: 10.1007/s13402-019-00477-5. Epub 2019 Nov 1.
8
The Tumor Microenvironment Innately Modulates Cancer Progression.肿瘤微环境先天调节癌症进展。
Cancer Res. 2019 Sep 15;79(18):4557-4566. doi: 10.1158/0008-5472.CAN-18-3962. Epub 2019 Jul 26.
9
Treatment outcomes of differentiated thyroid cancer with distant metastasis improve by tyrosine kinase inhibitors.酪氨酸激酶抑制剂可改善分化型甲状腺癌远处转移的治疗效果。
Oncol Lett. 2019 Jun;17(6):5292-5300. doi: 10.3892/ol.2019.10180. Epub 2019 Mar 21.
10
High-Mobility Group Box 1 (HMGB1) Promotes Angiogenesis and Tumor Migration by Regulating Hypoxia-Inducible Factor 1 (HIF-1α) Expression via the Phosphatidylinositol 3-Kinase (PI3K)/AKT Signaling Pathway in Breast Cancer Cells.高迁移率族蛋白 B1(HMGB1)通过调节乳腺癌细胞中的磷脂酰肌醇 3-激酶(PI3K)/AKT 信号通路调控缺氧诱导因子 1(HIF-1α)表达促进血管生成和肿瘤迁移。
Med Sci Monit. 2019 Apr 1;25:2352-2360. doi: 10.12659/MSM.915690.